Pharmacologic targeting of coagulation factors XII and XI by monoclonal antibodies reduces thrombosis in nitinol stents under flow
Journal Article
Overview
publication date
- May 1, 2024
has subject area
- Animal Diseases - Disease Models, Animal
- Animals
- Biological Factors - Factor XI
- Biological Factors - Factor XII
- Biomedical and Dental Materials - Alloys
- Blood Coagulation
- Blood Proteins - Antibodies, Monoclonal
- Blood Proteins - Factor XI
- Blood Proteins - Factor XII
- Cardiovascular Agents - Fibrinolytic Agents
- Enzymes and Coenzymes - Factor XI
- Enzymes and Coenzymes - Factor XII
- Fibrin Modulating Agents - Fibrinolytic Agents
- Globulins - Antibodies, Monoclonal
- Hematologic Agents - Fibrinolytic Agents
- Humans
- Immunoproteins - Antibodies, Monoclonal
- Male
- Manufactured Materials - Alloys
- Metals - Alloys
- Models, Animal - Disease Models, Animal
- Models, Biological - Disease Models, Animal
- Protein Precursors - Factor XI
- Protein Precursors - Factor XII
- Regional Blood Flow
- Stents
- Thrombosis
has restriction
- hybrid
Date in CU Experts
- March 20, 2024 2:24 AM
Full Author List
- Keeling NM; Wallisch M; Johnson J; Le HH; Vu HH; Jordan KR; Puy C; Tucker EI; Nguyen KP; McCarty OJT
author count
- 13
published in
Other Profiles
International Standard Serial Number (ISSN)
- 1538-7933
Electronic International Standard Serial Number (EISSN)
- 1538-7836
Digital Object Identifier (DOI)
Additional Document Info
start page
- 1433
end page
- 1446
volume
- 22
issue
- 5